RNA Interference News and Research

RSS

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Benitec Ltd. today announced the acquisition of Avocel, Inc. of Sunnyvale, CA, a leading RNAi therapeutics company, and the establishment of its wholly-owned US subsidiary, Benitec, Inc. Through the acquisition, Benitec gains its first in-house advanced therapeutic development program using DNA-directed RNAi (ddRNAi) to target the Hepatitis C virus.

18 May 2004

Mystery surrounding ageing, death and cancer is dispelled by new study

Scientists from Cancer Research UK and Breast Cancer Campaign have uncovered the first evidence of an entirely new system for holding the ravages of time at bay.

29 Apr 2004

Cancer could be inactivated by RNA library

CANCER RESEARCH UK and the Netherlands Cancer Institute have completed the first stage of a landmark initiative to systematically uncover the function of our genes, the charities announce today.

14 Apr 2004

Researchers turn off individual human genes to study their function

Researchers have produced vast libraries of short segments of ribonucleic acid (RNA) that can be used to turn off individual human and mouse genes to study their function. The libraries will be made widely available to laboratories studying human biology and disease. The researchers are optimistic that the libraries will become a powerful research tool for gene analysis and discovery.

25 Mar 2004

RNA Interference News and Research

Benitec acquires Avocel to focus on rapid development of hepatitis C therapeutics

Mystery surrounding ageing, death and cancer is dispelled by new study

Cancer could be inactivated by RNA library

Researchers turn off individual human genes to study their function

One Health, One Mission: The World Organisation for Animal Health on the AMR Frontline

Uniting Against Resistance: The World Health Organization for World Antimicrobial Awareness Week 2023

Tackling Antimicrobial Resistance: A Conversation with Dr. Beverley Isherwood

Latest News